The Global Fund’s largest private sector contributor (PRODUCT)REDTM, has passed a funding milestone of US$ 150 million to support Global Fund HIV and AIDS programs in Rwanda, Lesotho, Swaziland, Ghana, Zambia and South Africa. (PRODUCT)RED is today one of the largest consumer-based private sector initiatives to raise money for an international humanitarian cause.
UGANDA has received $20m (about sh40b) from the Global Fund to fight HIV and malaria. the Uganda AIDS Commission (UAC) boss, Dr. Kihumuro Apuuli, said an announcement was made to that effect early last week.
From an initiative that’s reaching 3.5 million people threatened by TB to a massive expansion of access to cheap anti-malaria medication in 24 African countries, businesses are doing work that is complementing the global health work of governments and international agencies. The companies behind this work are getting together with governments and non-profits on June 8 to recognize what’s working best, and to focus on doing more in the fight against global epidemics.
Our Action partners, Kenya AIDS NGOs Consortium (KANCO) was recently featured in the Kenyan newspaper “The Sunday Express”. The article highlights the problem of TB in Kenya, including MDR-TB, and quotes KANCO’s TB project manager, Evelyn Kibuchi, on KANCO’s efforts to fight TB in Kenya.
Today, London-based designer Markus Lupfer unveiled his limited-edition Malaria No More ‘net dress’ for the UK online fashion store ASOS.
William Bishai, a tuberculosis specialist, was today named as the director of the first Howard Hughes Medical Institute (HHMI) research laboratory outside the United States. HHMI will invest US$70 million over ten years in the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) being built in Durban, South Africa. Bishai will take up the post in September.
Every country, rich and poor, should ensure universal coverage of primary health care, including safe childbirth, nutrition, vaccines, malaria control, and clinical services. Each year, nearly nine million children die of conditions that could be prevented or treated, and nearly 400,000 women die because of complications during pregnancy.
Directors of UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria commended President Bingu wa Mutharika on Malawi’s progress in the AIDS response and his leadership as Chairperson of the African Union on AIDS, health, food security and development.
GlaxoSmithKline (GSK) has decided to team up with well known public domain data providers, European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD). Their aim is to make available important scientific information of over 13,500 compounds that eventually contributes to the invention of new malaria treatments.
Authorities are discovering a growing number of tuberculosis patients who have travelled by air while contagious, several of them potentially exposing other passengers to the most worrisome, drug-resistant strains of the disease, public-health alerts suggest.